REPCF fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
REPCF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company